We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Pharmacovigilance – News and Features

Person holding a GLP-1 injectable pen, ready for use, with cap removed.
News

Semaglutide Helps Schizophrenia Patients Lose Weight Without Side Effects

In a 36-week study, semaglutide was found to aid in weight loss for people with schizophrenia without worsening psychotic symptoms. Participants lost nearly 14% of body weight, and there was an improvement in lean mass to fat mass ratio.
3D rendered image of cancer cells grouped together.
News

Could Sea Cucumbers Be Key to Stopping Cancer Spread?

Sea cucumbers are the ocean's janitors, cleaning the seabed and recycling nutrients back into the water. But this humble marine invertebrate could also hold the key to stopping the spread of cancer.
A close up of a persons arm attached to a machine for measuring high blood pressure.
News

Common Antibiotic Could Provide a Template for New Blood Pressure Drugs

Scientists have discovered a surprising new role for a commonly used antibiotic that could open the door to a new family of improved therapies for high blood pressure and cardiovascular disease.
A woman eating a salad with a knife and fork.
News

These Brain Circuits That Tell Us When to Eat – and When to Stop

Two new research papers have mapped out which pathways in the brain are responsible for driving hunger, food seeking and satiety. The findings could help to refine weight-loss drugs and reduce their side effects.
A researcher in PPE holding up a red pill, representing drug discovery.
News

Next-Generation Weight Loss Drug Combines Elements of Four Hormones

Combining elements of four hormones into a single drug, researchers hope a next-generation weight loss drug will address not only obesity, but associated conditions like type 2 diabetes, cancer, and cardiovascular disease.
Futuristic representation of drug discovery with a digital capsule containing molecular structures.
News

Once-Weekly Oral Risperidone Shows Promise in Schizophrenia Treatment

The STARLYNG-1 trial tested a weekly oral version of risperidone for schizophrenia, showing it maintains therapeutic drug levels and reduces side effects. The study found that the weekly pill may help improve medication adherence.
Individual on a running track in the "start" position, ready to run.
Article

Why Exercise Matters for Those Facing Cancer

This article examines how physical activity and exercise influence cancer prevention, mitigate treatment-related side effects, enhance quality of life and impact overall mortality in oncology patients.
A person holding an injectable drug pen containing weight loss drug.
News

GLP-1 Medications Produce Smaller Weight Loss in a Real-World Setting

Injectable GLP-1 drugs for obesity have been found to produce smaller weight loss in a real-world setting compared to randomized clinical trials because patients discontinue treatment or use lower maintenance dosages.
Scoop resting on a pile of powdered creatine supplement against a dark background.
News

Creatine Benefits Extend Beyond Athletic Performance

Creatine, known for enhancing athletic performance, offers wide-ranging health benefits, including support for muscle mass and cognitive function. It’s especially useful for aging adults, athletes and vegetarians.
An E.coli bacterium with long flagella.
News

Energy Crisis Caused by Antibiotics Accelerates Resistance in E. coli

Antibiotics throw bacteria into an energy crisis that alters their metabolism and speeds up the evolution of antibiotic resistance.
Advertisement